These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33711455)

  • 21. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome?
    Gersch H; Shah D; Chroust A; Bailey B
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial.
    Czynski AJ; Laptook AR
    R I Med J (2013); 2021 Apr; 104(3):17-21. PubMed ID: 33789403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
    Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
    Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the literature: How does prenatal opioid exposure impact placental health and fetal brain development?
    Humphries A; Simcox K; Howell B
    Dev Psychobiol; 2023 Apr; 65(3):e22378. PubMed ID: 36946682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome.
    van Hoogdalem MW; Wexelblatt SL; Akinbi HT; Vinks AA; Mizuno T
    Pharmacol Ther; 2022 Jun; 234():108045. PubMed ID: 34813863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
    Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
    Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
    Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential problems and solutions of opioid-based treatment in neonatal opioid withdrawal syndrome (NOWS): a scoping review protocol.
    Mills-Huffnagle S; Nyland JE
    BMJ Open; 2023 Feb; 13(2):e067883. PubMed ID: 36806065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.
    Mahnke AH; Roberts MH; Leeman L; Ma X; Bakhireva LN; Miranda RC
    Sci Rep; 2022 Apr; 12(1):5941. PubMed ID: 35396369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fetal gastric area ratio to predict severe neonatal opioid withdrawal syndrome.
    Townsel C; Stone J; Debolt C; Hussain N; Campbell WA
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7957-7961. PubMed ID: 34151686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placental cytochrome P450 methylomes in infants exposed to prenatal opioids: exploring the effects of neonatal opioid withdrawal syndrome on health horizons.
    Radhakrishna U; Sadhasivam S; Radhakrishnan R; Forray A; Muvvala SB; Metpally RP; Patel S; Rawal RM; Vishweswaraiah S; Bahado-Singh RO; Nath SK
    Front Genet; 2023; 14():1292148. PubMed ID: 38264209
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
    Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
    J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated With the Need for Pharmacological Management of Neonatal Opioid Withdrawal Syndrome.
    Scott LF; Guilfoy V; Duwve JM; Rawl SM
    Adv Neonatal Care; 2020 Oct; 20(5):364-373. PubMed ID: 32868586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebral perfusion and neurological examination characterise neonatal opioid withdrawal syndrome: a prospective cohort study.
    Benninger KL; Peng J; Ho ML; Newton J; Wang DJJ; Hu HH; Stark AR; Rusin JA; Maitre NL
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):414-420. PubMed ID: 34725106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero.
    Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376
    [No Abstract]   [Full Text] [Related]  

  • 38. Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
    Devlin LA; Young LW; Kraft WK; Wachman EM; Czynski A; Merhar SL; Winhusen T; Jones HE; Poindexter BB; Wakschlag LS; Salisbury AL; Matthews AG; Davis JM
    J Perinatol; 2022 Mar; 42(3):300-306. PubMed ID: 34556799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infant Mortality Associated With Prenatal Opioid Exposure.
    Leyenaar JK; Schaefer AP; Wasserman JR; Moen EL; O'Malley AJ; Goodman DC
    JAMA Pediatr; 2021 Jul; 175(7):706-714. PubMed ID: 33843963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.
    Oji-Mmuo CN; Jones AN; Wu EY; Speer RR; Palmer T
    Neurotoxicol Teratol; 2021; 86():106978. PubMed ID: 33838247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.